Business ❯ Corporate Governance ❯ Investor Relations

Public Companies

Securities Fraud Stock Market Securities Financial Reporting Securities Offerings Altimmune, Inc. Stock Performance James Hardie Industries Stockholder Actions Securities Regulation Market Reactions Trade Desk, Inc. Telix Pharmaceuticals Capricor Therapeutics Shareholder Rights NASDAQ LifeMD, Inc. C3.ai, Inc. Savara Inc. Market Performance Iovance Biotherapeutics Enphase Energy Shanghai Stock Exchange CarMax, Inc. Securities Regulations Baxter International Inc. KBR, Inc. Cytokinetics Product Launches Disclosure Obligations Shareholder Activism Stock Acquisition Agilon Health, Inc. IPO Performance Mereo BioPharma Group Five Below, Inc. BellRing Brands Bumble Inc. Chipotle Mexican Grill Stockholder Communication Securities Transactions Revance Therapeutics Pharmaceutical Industry Skyworks Solutions, Inc. Stockholder Rights DoubleVerify Holdings, Inc. BellRing Brands, Inc. Tronox Holdings plc Replimune Group, Inc.

Securities Suit Targets monday.com Ahead of May 11 Lead‑Plaintiff Deadline

Plaintiffs say a February reversal on revenue targets revealed earlier misstatements, hurting shareholders.

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

Law Firms Urge CoreWeave Investors to Seek Lead Role in Securities Class Action Before March 13

Varonis Investors Face March 9 Deadline to Lead Securities Class Action Over SaaS Conversion Claims

Bitdeer Investors Face Feb. 2 Deadline to Seek Lead Role in Securities Suit Over SEAL04 Disclosures

Law Firms Seek Agilon Health Investors Ahead of March 2 Lead Plaintiff Deadline in Securities Case

Vistagen Faces Federal Securities Class Action After Fasedienol Phase 3 Failure

StubHub Investors Face Jan. 23 Lead-Plaintiff Deadline in IPO Disclosure Lawsuits

Smart Digital Sued in SDNY Securities Class Action as Trading Halt Persists

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Jayud Securities Class Action Approaches Lead-Plaintiff Deadline as Investor Firms Mobilize

Varonis Investors Face March 9 Lead Plaintiff Deadline in Securities Class Action

Skye Bioscience Faces Investor Class Actions as Firms Court Shareholders Before Jan. 16 Deadline

DeFi Technologies Investors Face Jan. 30 Lead‑Plaintiff Deadline in Federal Securities Case

Plaintiffs’ Firms Urge StubHub IPO Investors to Act as Lead‑Plaintiff Deadline Nears